COVID-19 Update for the Marfan, Loeys-Dietz, and VEDS Community
51:48-54:01
Joe, could I just add a couple of points and one of these is Dr. Nunez, kind of mentioned but I, I wanted to reinforce the fact that the recommendation currently is that these vaccines are safe for pregnant women and so we no longer have that kind of question as to whether women who are pregnant should be vaccinated. We now know and the, the CDC has stated without any kind of hesitation that they should be vaccinated.
私の方から、何点か付け加えたいのですがよろしいでしょうか？Nunez先生も触れたことかもしれませんが、私からも再度強調したいと思います。COVIDワクチンの妊婦への接種ですが、現在は推奨されています。CDCも積極的に妊婦のワクチン接種を推奨しています。
And we also know in the studies that, that are currently available that children are able to achieve a very, very high level probably higher than adults of protective immunity when they're vaccinated.
さらに、子供がワクチンを接種することで、非常に高い保護効果が得られるという研究結果も出ており、おそらくは、成人よりも効果が高いということです。
So we have further evidence that these vaccines are game changers and they are exceedingly kind of effective.
ということで、ワクチンは予想を遥かに超えて効果が高いことを示すエビデンスが得られました。
And so what we need to wait for, which is what Dr. Eagle was, was discussing, is more data about the vaccines in relation to these different variants and we will see more and more variants. It's, it's basically a function of the number of people who are infected and so as the number of people who are infected goes down the number of variants that will emerge will also go down.
次に知りたいこととしては、Eagle先生もおっしゃっていたように、今後も増えるであろう変異型に対するワクチンの効果です。変異型は感染する方の数に応じて変化しますので、感染者数が低下すれば、それに応じて変異型の数も減ってくるでしょう。
Can I just add to that then? I'm piling on. That was such an important comment and I think within the past two weeks both Moderna and Pfizer have indicated that they will be recommending a booster to their vaccine program in the fall.
私の方からも付け加えます。Enid先生のご指摘は非常に重要だと思います。ここ2週間ほどの間にModerna社とPfizer社から、今年の秋には追加のワクチン接種が必要となるとの発表がありました。
And I think this probably illustrates two features: one is that the immune response may drift a little bit after six to nine months and not be quite as robust and second they may be building in additional sequences that will allow the next boost to target some of the variants that perhaps are more infectious.
理由としては、2つあると考えています。1つ目は、ワクチン接種から6～9ヶ月で免疫反応が多少弱まる可能性があるということ、2つ目として、ワクチンに遺伝子配列を追加することで、より感染力が強いと思われる変異型の一部を標的にするためです。
The Marfan Foundation did not participate in the translation of these materials and does not in any way endorse them. If you are interested in this topic, please refer to our website, Marfan.org, for materials approved by our Professional Advisory Board.
The Marfan Foundation は、当翻訳には関与しておらず、翻訳内容に関してはいかなる承認も行っておりません。このトピックに興味をお持ちの方は、Marfan.org にアクセスし、当協会の専門家から成る諮問委員会が承認した内容をご参照ください。
